*Result*: Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial
*Author/editor-in-chief*:
Chen, Yi-Bin (Verfasser); Mohty, Mohamad (Verfasser); Zeiser, Robert (Verfasser) ; Teshima, Takanori (Verfasser); Jamy, Omer (Verfasser); Maertens, Johan (Verfasser); Purtill, Duncan (Verfasser); Chen, Jingjing (Verfasser); Cao, Hong (Verfasser); Rossiter, Guillermo (Verfasser); Jansson, Johan (Verfasser); Fløisand, Yngvar (Verfasser)
*Publication*:
Freiburg : Universität, 2024
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Nature medicine. - 30, 8 (2024) , 2277-2287, ISSN: 1546-170X
*DOI*:
10.1038/s41591-024-03016-4